焦树德治疗结核性胸膜炎经验应用效果解析.docVIP

 PAGE 7 作者简介：陈杰勇（1978-），男，河北衡水人，主治医师，学士，研究方向：肺结核、结核性胸膜炎、麻疹等呼吸道传染疾病,电子支气管镜应用。Tel0318-2394418，E-mail: HYPERLINK mailto:chenjieyong66@ chenjieyong66@。 焦树德治疗结核性胸膜炎经验应用效果分析 陈杰勇 (衡水市第三人民医院，河北　衡水 　053000) 摘要: 目的:探讨焦树德治疗结核性胸膜炎经验在缩短胸水消失时间及防止胸膜肥厚粘连的临床疗效。方法：64 例中至大量游离结核性胸腔积液患者随机分为治疗组和对照组。治疗组在抗痨及常规胸穿抽液的基础上加用中药治疗。统计治疗3个月后2组进行效果分析。结果：59 例患者参与最后结果分析。治疗3个月后治疗组、对照组胸膜肥厚发生 率是 6.7 %、31.0 %(有效率分别是:93.3 %、69.0 %) ( P 0.05) ；治疗组胸腔积液消失时间短,具有极显著性???异。结论：应用焦树德经验采用中西医联合治疗可显著缩短胸水吸收时间,有效防止胸膜肥厚粘连的发生。 关键词：结核性胸膜炎；胸腔积液；胸膜肥厚；悬饮；中西医结合疗法 Applying Effect Analysis of Jiao Shude’s Tuberculosis Pleurisy Therapy CHEN Jie-Yong (The 3rd People’s Hospital of Hengshui City,Hengshui 053000, Hebei, China) Abstract: Objective: To explore the clinic effect of Jiao Shude’s tuberculosis pleurisy therapy in decreasing the vanishing time of hydrothorax and preventing pleura thickening and adhesion. Methods: Sixty-four patients with free tuberculosis pleural effusion, defined as middle to large pleural effusions, were randomized into two groups. Patients in treat group were given Chinese herbs treatment besides pasid and routine thoracentesis. Then analyze the statistics data of 2 groups’ treatment effect from the therapy started to three months after. Results: 59 patient s were available for final analysis. The incidence rate of residual pleural thickening at 3rd month were 6.7 % in treatment group and 31.0 % in control group (the effective rates are 93.3 % vs.69.0 % separately) ( P 0.05) ；the vanishing time of pleural effussion in treat group is significant shorter than control group. Conclusion: to apply Jiao Shude’s therapy in tuberculosis pleurisy, which combines traditional Chinese and western medicine, can significantly decrease the vanishing time of pleural effussion, and effectively prevent pleura thickening. Key Word: Tuberculosis Pleurisy; Pleural Effusion；Residual Pleural Thickening; therapy of combining traditional Chinese and Western medicine 目前,结核病仍是全球发病率及死亡率最高的可防治的感染性疾病。结核性胸膜炎是肺